Matthew Allister Cooper, PhD
NHMRC Principal Research Fellow and Professor of Chemistry & Structural Biology at University of Queensland
Location: Brisbane, Queensland, Australia
Prof. Matt Cooper completed his PhD in 1995 and then spent 13 years in the United Kingdom, first at the University of Cambridge, then nine years in start-ups and biotechnology companies. He returned to Australia in 2009 as a NHMRC Australia Fellow at the University of Queensland, where he is driving research and development of infectious and inflammatory disease diagnostics and therapeutics. He was founder and managing director of Cambridge Medical Innovations (part of Alere Inc.), CSO and co-founder of Akubio, and co-founder of Defensin Therapeutics. He has more than 190 scientific articles, two books and 22 patents, and has helped launch multiple medical technology products on the market today.